Markets
Nifty Pharma: uptrend since April 2026
Nifty Pharma has been in an uptrend since April 2026 (7 months). Its trend score is 100 out of 100, nearly all signals up. On momentum it is among the leaders, 6th of 139, and 6th of 23 in sectors.
Written for anyone holding or watching Nifty Pharma. Data to 20 Nov 2026.
- Trend
- Uptrend since Apr 2026
- Momentum
- 6th of 139 markets, by rank
- Below its high
- 1.7% total return
- P/E
- 45.7 100th percentile since 2021
- 1 year
- +25.9% total return
Today
Of 7 earlier uptrends in Pharma that lasted 7 months or more, 86% went on for at least another three months and 43% for six. Across sectors indices (since each launch): 76% and 53% of 83.
- Trend
- Uptrend since April 2026score 100 of 100; four weeks ago 46
- Momentum rank
- 6th of 23in sectors; 6th of 139 markets overall
- The 10-month rule
- holding since April 2026month-end price against its 10-month average
- The 200-day rule
- holding since April 2026daily close against its 200-session average
| Signal | 1 month1m | 2 months2m | 3 months3m | 6 months6m | 9 months9m | 12 months12m | Up |
|---|---|---|---|---|---|---|---|
| Past returnhigher than it was that long ago | Up | Up | Up | Up | Up | Up | 6 of 6 |
| Price against its averageabove its average over the period | Up | Up | Up | Up | Up | Up | 6 of 6 |
| Fast average against slowa quarter-length average above the full-length one | Up | Up | Up | Up | Up | Up | 6 of 6 |
| Place in its rangein the upper half of the period's high-low range | Up | Up | Up | Up | Up | Up | 6 of 6 |
| Up at this horizon | 4 of 4 | 4 of 4 | 4 of 4 | 4 of 4 | 4 of 4 | 4 of 4 | 24 of 24 |
By speed. 8 of the 8 one- and two-month signals point up, 8 of the 8 three- and six-month ones and 8 of the 8 nine- and twelve-month ones. Fast signals react first and turn most often; slow ones confirm. Tested across markets, no speed beat another by more than luck, and none beat holding after tax (the evidence).
| Over the last | 1 month1M | 3 months3M | 6 months6M | 12 months12M |
|---|---|---|---|---|
| Return over cash | +10.5% | +6.4% | +11.6% | +19.2% |
| Percentile | 73 | 93 | 92 | 100 |
Trend over time
The trend score each week since 2002, and the trends it marks: an uptrend from the week the score reaches 70 until it falls to 30, and a downtrend the other way.
Pharma: trend score, week by week
Share of 24 trend signals pointing up, 0 to 100, weekly to 20 Nov 2026; the 13-week average in bold. Before Jul 2005 the index is NSE's back-calculation.
How to read it. The score moves fast because a third of its signals look back only one or two months. Long stretches near 100 or 0 are the strong trends; the lines at 70 and 30 are where a trend starts.
Loading chart…
Uptrends and downtrends
Weekly; blank before the first trend was established.
How to read it. 31 uptrends and 30 downtrends since 2002. Hover for the dates; the next section has each one's return.
Loading chart…
Pharma: fast, medium and slow signals
Share of the 8 signals up at each speed (four signal types at two horizons), weekly, last two years. The three average to the trend score.
How to read it. The fast line swings from 0 to 100 within weeks; the slow line moves over months. When fast sits near 0 while slow sits near 100, the market is dipping inside a longer uptrend; the reverse is a bounce inside a longer fall.
Loading chart…
Which horizons are rising
Up signals out of four at each horizon, weekly, last three years. Blue: all four up; red: all four down.
How to read it. Trends turn from the top row down: the one-month signals flip first and the twelve-month ones last. Red spreading down the rows is a downtrend taking hold; blue spreading down is a recovery being confirmed.
Against its peers
Pharma ranks 6th of 23 in sectors on momentum; thirteen weeks ago it was 3rd of 23. Momentum here is the return over cash at 1, 3, 6 and 12 months, each ranked, then averaged.
Pharma: place among sectors, week by week
Momentum rank within the family, last three years: 100 is first, 0 is last, of the 23 live members.
How to read it. A market that leads its family for months shows as a long stretch near the top; one that swings from top to bottom takes turns with its peers.
Pharma: place among sectors, week by week. Line chart, 24 Nov 2023 to 20 Nov 2026. Place in sectors: latest 77, range 9 to 100.
Sectors, ranked by momentum on 20 Nov 2026. "13 weeks ago" is the rank then, among the members live then.
| Rank | Market | 13 weeks ago | Places gained | Trend | Score | 3 months over cash | 12 months over cash | More |
|---|---|---|---|---|---|---|---|---|
| 1 | PSU Bank | 12 | +11 | Uptrend since Nov 2026 | 92 | +13.1% | +13.5% | |
| 2 | Private Bank | 17 | +15 | Uptrend since Nov 2026 | 96 | +14.8% | +7.2% | |
| 3 | Bank | 16 | +13 | Uptrend since Nov 2026 | 88 | +11.4% | +5.5% | |
| 4 | Financial Services | 19 | +15 | Uptrend since Nov 2026 | 83 | +9.6% | +0.7% | |
| 5 | Nifty500 Healthcare | 9 | +4 | Uptrend since Oct 2026 | 96 | +4.8% | +14.0% | |
| 6 | Pharma (this page) | 3 | −3 | Uptrend since Apr 2026 | 100 | +6.4% | +19.2% | |
| 7 | Healthcare | 14 | +7 | Uptrend since Oct 2026 | 96 | +5.0% | +12.3% | |
| 8 | MidSmall Healthcare | 4 | −4 | Uptrend since Oct 2026 | 100 | +3.5% | +16.7% | |
| 9 | Media | 7 | −2 | Uptrend since Jun 2026 | 100 | +9.2% | +13.0% | |
| 10 | Financial Services 25/50 | 20 | +10 | Uptrend since Nov 2026 | 79 | +7.1% | −1.9% | |
| 11 | Realty | 10 | −1 | Uptrend since Nov 2026 | 92 | +3.4% | −5.2% | |
| 12 | Auto | 1 | −11 | Uptrend since Nov 2026 | 79 | −2.7% | +0.6% | |
| 13 | REITs & Realty | 11 | −2 | Uptrend since Nov 2026 | 88 | −0.6% | −1.4% | |
| 14 | MidSmall Financial Services | 6 | −8 | Uptrend since Nov 2026 | 75 | −1.6% | +5.5% | |
| 15 | Financial Services Ex-Bank | 13 | −2 | Uptrend since Nov 2026 | 75 | −1.5% | −2.8% | |
| 16 | Consumer Durables | 5 | −11 | Uptrend since Nov 2026 | 71 | −5.7% | −3.9% | |
| 17 | MidSmall IT & Telecom | 2 | −15 | Uptrend since Jul 2026 | 83 | +0.8% | −6.0% | |
| 18 | Oil & Gas | 21 | +3 | Downtrend since Mar 2026 | 67 | +2.0% | −9.6% | |
| 19 | FMCG | 23 | +4 | Downtrend since Sep 2025 | 63 | +1.1% | −16.0% | |
| 20 | IT | 15 | −5 | Uptrend since Oct 2026 | 63 | +1.8% | −17.8% | |
| 21 | Cement | 22 | +1 | Downtrend since Nov 2025 | 54 | −1.2% | −13.4% | |
| 22 | Metal | 8 | −14 | Downtrend since Oct 2026 | 33 | −6.8% | +11.1% | |
| 23 | Chemicals | 18 | −5 | Downtrend since Sep 2026 | 42 | −7.0% | −6.8% |
Pharma: momentum rank among all markets, week by week
0 to 100 among every market with a year of history that week (today 139), not only its family.
How to read it. Near 100 it is rising faster than almost everything else, near 0 slower, whatever the market as a whole is doing.
Loading chart…
What followed each trend
Pharma has had 31 uptrends and 30 downtrends since 2002. A year after an uptrend began it had risen by a median +17.2% (28 cases); a year after a downtrend began, +17.4% (28). From any week, the usual year was +14.8%.
Median return of Pharma, total return, over the 3, 6 and 12 months after the week each trend began, and the share of cases that ended higher. The last row is the same measure from every week, the yardstick for the other two.
| Starting point | 3 months | Higher | 6 months | Higher | 12 months | Higher | Cases | More |
|---|---|---|---|---|---|---|---|---|
| After an uptrend began | +4.8% | 68% | +12.7% | 71% | +17.2% | 71% | 28 | |
| After a downtrend began | +1.3% | 60% | +4.5% | 67% | +17.4% | 75% | 28 | |
| From any week (the usual) | +3.3% | 64% | +7.1% | 69% | +14.8% | 72% | 1,297 |
How much to read into this. These are descriptions of Pharma's past, not a tested signal. The trends overlap with each other's next twelve months, and a trend is only called after the market has already moved, so its "during" return includes the climb that called it. 13 of the 61 trends fall in NSE's back-calculated history before the index launched. Whether these patterns hold across markets is the subject of the tests on the evidence page.
Every uptrend and downtrend in Pharma, newest first. Returns are from the close of the week each began; a trend still going is measured to 20 Nov 2026.
| Trend | Began | Ended | Lasted | Return during | Next 3 months | Next 6 months | Next 12 months | History | More |
|---|---|---|---|---|---|---|---|---|---|
| Uptrend | Apr 2026 | still going | 7 months | +22.5% | +14.4% | +16.9% | – | – | |
| Downtrend | Apr 2026 | Apr 2026 | 4 weeks | +3.5% | +17.9% | +22.2% | – | – | |
| Uptrend | Feb 2026 | Mar 2026 | 5 weeks | −1.7% | +5.8% | +16.6% | – | – | |
| Downtrend | Jan 2026 | Feb 2026 | 6 weeks | +1.3% | +1.3% | +16.0% | – | – | |
| Uptrend | Nov 2025 | Jan 2026 | 2 months | −0.3% | −2.6% | +9.3% | – | – | |
| Downtrend | Sep 2025 | Nov 2025 | 7 weeks | +3.1% | +4.8% | +1.7% | +24.2% | – | |
| Uptrend | Sep 2025 | Sep 2025 | 1 week | 0.0% | +1.1% | −1.7% | +18.7% | – | |
| Downtrend | Aug 2025 | Sep 2025 | 6 weeks | +4.4% | +5.6% | +5.0% | +23.9% | – | |
| Uptrend | Jul 2025 | Aug 2025 | 5 weeks | −1.4% | −2.4% | +3.7% | +16.7% | – | |
| Downtrend | Jan 2025 | Jun 2025 | 5 months | +2.6% | −1.3% | +3.1% | +3.3% | – | |
| Uptrend | Jun 2023 | Jan 2025 | 20 months | +67.2% | +18.3% | +24.5% | +48.6% | – | |
| Downtrend | Nov 2022 | Jun 2023 | 7 months | +0.3% | −4.1% | −3.0% | +24.1% | – | |
| Uptrend | Nov 2022 | Nov 2022 | 2 weeks | −3.0% | −9.2% | −6.1% | +16.6% | – | |
| Downtrend | Jan 2022 | Oct 2022 | 9 months | −0.7% | +1.1% | −6.4% | −4.8% | – | |
| Uptrend | Dec 2021 | Jan 2022 | 3 weeks | −1.8% | −2.8% | −13.7% | −9.6% | – | |
| Downtrend | Nov 2021 | Dec 2021 | 7 weeks | −2.0% | −1.7% | −6.2% | −5.9% | – | |
| Uptrend | Apr 2021 | Nov 2021 | 7 months | +13.1% | +17.4% | +19.5% | +12.4% | – | |
| Downtrend | Mar 2021 | Mar 2021 | 2 weeks | +1.9% | +20.2% | +23.7% | +17.0% | – | |
| Uptrend | Apr 2020 | Mar 2021 | 11 months | +39.1% | +15.0% | +37.2% | +46.3% | – | |
| Downtrend | Feb 2020 | Apr 2020 | 6 weeks | −2.7% | +33.3% | +51.1% | +64.5% | – | |
| Uptrend | Jan 2020 | Feb 2020 | 5 weeks | +1.0% | +13.7% | +26.6% | +51.7% | – | |
| Downtrend | May 2019 | Jan 2020 | 9 months | −6.0% | −10.6% | −13.1% | +7.0% | – | |
| Uptrend | Apr 2019 | May 2019 | 2 weeks | −2.5% | −14.7% | −15.2% | −0.1% | – | |
| Downtrend | Oct 2018 | Apr 2019 | 6 months | +3.3% | −4.9% | +1.2% | −11.9% | – | |
| Uptrend | Aug 2018 | Oct 2018 | 3 months | +1.8% | +1.7% | −5.2% | −18.5% | – | |
| Downtrend | Sep 2016 | Jul 2018 | 22 months | −20.4% | −10.0% | −8.0% | −16.8% | – | |
| Uptrend | Sep 2016 | Sep 2016 | 2 weeks | +0.6% | −10.0% | −10.5% | −17.4% | – | |
| Downtrend | Nov 2015 | Sep 2016 | 10 months | −3.0% | −5.5% | −8.2% | −13.0% | – | |
| Uptrend | Jul 2015 | Oct 2015 | 4 months | +5.4% | +4.8% | −9.4% | −6.5% | – | |
| Downtrend | Jun 2015 | Jul 2015 | 5 weeks | +4.7% | +9.9% | −0.5% | −8.1% | – | |
| Uptrend | Jun 2014 | May 2015 | 12 months | +57.5% | +31.3% | +36.3% | +51.2% | – | |
| Downtrend | May 2014 | Jun 2014 | 3 weeks | +2.4% | +33.6% | +51.1% | +56.2% | – | |
| Uptrend | Feb 2012 | May 2014 | 2.3 years | +59.5% | +5.4% | +12.2% | +22.5% | – | |
| Downtrend | Aug 2011 | Jan 2012 | 6 months | +6.0% | +1.2% | +6.2% | +21.9% | – | |
| Uptrend | Jul 2011 | Aug 2011 | 5 weeks | −2.7% | −6.3% | −1.6% | +9.2% | – | |
| Downtrend | Feb 2011 | Jul 2011 | 5 months | +9.1% | +5.6% | +3.9% | +10.4% | – | |
| Uptrend | May 2009 | Feb 2011 | 21 months | +80.7% | +9.8% | +39.4% | +58.5% | – | |
| Downtrend | Sep 2008 | May 2009 | 8 months | −19.2% | −25.1% | −28.5% | +9.2% | – | |
| Uptrend | Feb 2008 | Sep 2008 | 7 months | +11.1% | +12.6% | +13.0% | −30.6% | – | |
| Downtrend | Jan 2008 | Feb 2008 | 5 weeks | +5.2% | +24.5% | +22.2% | −20.0% | – | |
| Uptrend | Oct 2007 | Jan 2008 | 3 months | +4.3% | −5.3% | +17.9% | −18.6% | – | |
| Downtrend | Jul 2007 | Oct 2007 | 3 months | +0.1% | +0.1% | +7.4% | +20.3% | – | |
| Uptrend | Apr 2007 | Jul 2007 | 3 months | +1.6% | +1.6% | +1.9% | +12.9% | – | |
| Downtrend | Feb 2007 | Apr 2007 | 7 weeks | +3.4% | +10.2% | −2.5% | +7.8% | – | |
| Uptrend | Aug 2006 | Feb 2007 | 6 months | +7.1% | +4.3% | +6.6% | −3.6% | – | |
| Downtrend | Jun 2006 | Aug 2006 | 3 months | +1.9% | +7.5% | +13.0% | +18.1% | – | |
| Uptrend | Nov 2005 | May 2006 | 6 months | +18.9% | +17.1% | +18.5% | +27.7% | – | |
| Downtrend | Oct 2005 | Nov 2005 | 4 weeks | +2.3% | +9.2% | +36.5% | +31.3% | – | |
| Uptrend | May 2005 | Oct 2005 | 5 months | +11.3% | +11.2% | +12.9% | +22.9% | back-calculated | |
| Downtrend | Mar 2005 | May 2005 | 2 months | −1.7% | +7.5% | +15.6% | +43.4% | back-calculated | |
| Uptrend | Mar 2005 | Mar 2005 | 2 weeks | −1.6% | +1.5% | +12.7% | +32.3% | back-calculated | |
| Downtrend | Jan 2005 | Mar 2005 | 7 weeks | +5.0% | −2.8% | +17.8% | +22.2% | back-calculated | |
| Uptrend | Sep 2004 | Jan 2005 | 4 months | +8.5% | +15.4% | +13.2% | +28.6% | back-calculated | |
| Downtrend | Jun 2004 | Sep 2004 | 3 months | −1.3% | −1.1% | +16.0% | +17.8% | back-calculated | |
| Uptrend | May 2003 | May 2004 | 12 months | +70.2% | +40.2% | +60.5% | +75.7% | back-calculated | |
| Downtrend | Feb 2003 | May 2003 | 3 months | −0.9% | −2.2% | +32.6% | +81.6% | back-calculated | |
| Uptrend | Jan 2003 | Feb 2003 | 6 weeks | −2.0% | −4.6% | +22.3% | +84.0% | back-calculated | |
| Downtrend | Jul 2002 | Dec 2002 | 5 months | +1.5% | −9.4% | +2.5% | +29.0% | back-calculated | |
| Uptrend | Jul 2002 | Jul 2002 | 1 week | 0.0% | −10.9% | −2.0% | +17.7% | back-calculated | |
| Downtrend | May 2002 | Jul 2002 | 7 weeks | +5.2% | +2.0% | −4.6% | +7.6% | back-calculated | |
| Uptrend | Jan 2002 | May 2002 | 5 months | +4.6% | +11.2% | +4.3% | +6.2% | back-calculated |
After big moves
Pharma has fallen below its 200-day average 28 times. A year later it was higher 69% of the time, with a median return of +15.6%; from any day, 72% and +14.9%. The deepest fall within that year had a median of −7.8%, against −7.8% from any day.
What Pharma did after each kind of move since 2002: the median total return over the next 3, 6 and 12 months, how often it was higher a year later, and the median of the deepest fall within that year. A move counts once: a cross of the 200-day average after 20 sessions on the other side, a fall of 10% or 20% from a high (counted again only after a new high), a 52-week high after three months without one. The last row is every day, the yardstick.
| After it | Times | 3 months | 6 months | 12 months | Higher a year later | Deepest fall within a year | More |
|---|---|---|---|---|---|---|---|
| Fell below its 200-day average | 28 | +3.6% | +3.1% | +15.6% | 69% | −7.8% | |
| Rose back above it | 23 | +3.2% | +3.8% | +13.1% | 65% | −8.1% | |
| Fell 10% from its high | 15 | +1.7% | +9.1% | +8.2% | 67% | −10.3% | |
| Fell 20% from its high | 7 | +5.3% | +7.4% | +17.1% | 71% | −8.7% | |
| Made a new 52-week high | 17 | +8.0% | +12.2% | +21.4% | 81% | −6.6% | |
| Any day (the usual) | – | +3.4% | +7.2% | +14.9% | 72% | −7.8% |
Some of these are small samples. Where a move has happened fewer than ten times, one or two cases decide the median. These describe Pharma's own past; the moves overlap, and a fall or a cross is only visible after it has happened. Pooled across 106 investable markets since each launched, the returns after these moves did not differ from an ordinary day by more than luck would explain once all ten comparisons are counted. Two patterns came close: a year after a new 52-week high, returns were about 6 points above usual, and after a fall below the 200-day average the deepest fall in the next year was about 2 points worse. The full test is on the evidence page.
Every such move in Pharma, newest first. Blank where the period has not yet passed.
| Date | Move | 1 month | 3 months | 6 months | 12 months | Deepest fall in the year | History | More |
|---|---|---|---|---|---|---|---|---|
| 19 Mar 2026 | Below 200-day | +4.0% | +13.3% | +23.3% | – | – | – | |
| 20 Jan 2026 | Below 200-day | +4.0% | +4.2% | +20.1% | – | – | – | |
| 7 Jan 2026 | 52-week high | −5.6% | −4.9% | +12.2% | – | – | – | |
| 26 Sept 2025 | Below 200-day | +4.3% | +4.8% | +1.7% | +24.2% | −0.2% | – | |
| 6 Aug 2025 | Below 200-day | +1.6% | +4.1% | +3.8% | +23.7% | −0.5% | – | |
| 11 Jun 2025 | Above 200-day | +0.4% | +0.8% | +3.8% | +11.0% | −2.8% | – | |
| 24 Apr 2025 | Above 200-day | −2.1% | +2.3% | +2.2% | +6.7% | −4.1% | – | |
| 27 Jan 2025 | Down 10% | −4.0% | +1.8% | +9.1% | +1.9% | −6.7% | – | |
| 27 Jan 2025 | Below 200-day | −4.0% | +1.8% | +9.1% | +1.9% | −6.7% | – | |
| 17 Nov 2023 | 52-week high | +3.7% | +20.7% | +21.9% | +41.3% | never below | – | |
| 28 Jun 2023 | 52-week high | +10.3% | +10.8% | +24.4% | +49.4% | −0.1% | – | |
| 12 Apr 2023 | Above 200-day | −0.7% | +10.5% | +21.8% | +48.5% | −3.6% | – | |
| 18 Nov 2022 | Below 200-day | −1.7% | −4.1% | −3.0% | +24.1% | −9.5% | – | |
| 30 Sept 2022 | Above 200-day | +4.5% | −3.2% | −5.8% | +17.4% | −10.3% | – | |
| 17 Jun 2022 | Down 20% | +7.8% | +5.3% | +7.4% | +12.6% | −1.0% | – | |
| 8 Apr 2022 | Above 200-day | −10.2% | −9.1% | −6.7% | −8.1% | −15.5% | – | |
| 28 Dec 2021 | Above 200-day | −7.1% | −0.4% | −11.8% | −8.6% | −14.4% | – | |
| 22 Nov 2021 | Down 10% | +0.3% | 0.0% | −5.1% | −1.3% | −10.6% | – | |
| 17 Nov 2021 | Below 200-day | −2.9% | −1.2% | −5.1% | −4.7% | −13.1% | – | |
| 20 Apr 2021 | 52-week high | +4.2% | +7.9% | +6.0% | +0.8% | −6.3% | – | |
| 18 Mar 2021 | Below 200-day | +16.2% | +22.4% | +25.0% | +19.0% | never below | – | |
| 22 Feb 2021 | Down 10% | −1.0% | +15.8% | +16.4% | +8.2% | −4.3% | – | |
| 21 Apr 2020 | 52-week high | +1.5% | +8.4% | +24.1% | +42.7% | −3.2% | – | |
| 16 Jan 2020 | Above 200-day | +1.6% | +14.9% | +24.5% | +55.3% | −21.2% | – | |
| 12 Mar 2019 | Above 200-day | +1.3% | −14.0% | −14.0% | −24.2% | −27.4% | – | |
| 25 Oct 2018 | Below 200-day | −0.9% | −2.7% | +1.7% | −12.6% | −21.2% | – | |
| 23 Aug 2018 | 52-week high | +1.8% | −10.4% | −12.2% | −20.2% | −23.2% | – | |
| 16 Jul 2018 | Below 200-day | +8.2% | +10.3% | −0.2% | −7.2% | −10.9% | – | |
| 14 Jun 2018 | Above 200-day | +0.6% | +17.4% | −2.6% | −12.3% | −14.0% | – | |
| 27 Dec 2017 | Above 200-day | +0.9% | −10.6% | −4.8% | −8.3% | −17.2% | – | |
| 2 Nov 2017 | Above 200-day | −9.2% | −8.4% | −12.5% | −3.1% | −20.2% | – | |
| 17 Oct 2016 | Below 200-day | −6.4% | −7.4% | −8.5% | −14.4% | −24.4% | – | |
| 10 Aug 2016 | Below 200-day | +2.4% | −5.3% | −8.4% | −22.2% | −24.7% | – | |
| 11 Jul 2016 | Above 200-day | −1.1% | −3.2% | −10.6% | −14.5% | −25.2% | – | |
| 21 Jan 2016 | Down 20% | +5.6% | +2.9% | +6.7% | −3.9% | −8.7% | – | |
| 6 Nov 2015 | Below 200-day | −7.0% | −5.5% | −8.2% | −13.0% | −13.3% | – | |
| 9 Jun 2015 | Below 200-day | +8.9% | +10.4% | +0.3% | −4.7% | −5.8% | – | |
| 21 Apr 2015 | Down 10% | +2.2% | +7.4% | +8.9% | −8.5% | −12.7% | – | |
| 27 Jun 2014 | 52-week high | +10.5% | +28.8% | +27.9% | +49.1% | never below | – | |
| 19 May 2014 | Down 10% | +8.4% | +29.7% | +51.6% | +69.7% | never below | – | |
| 19 May 2014 | Below 200-day | +8.4% | +29.7% | +51.6% | +69.7% | never below | – | |
| 21 Aug 2013 | Down 10% | +11.9% | +12.4% | +21.8% | +56.7% | never below | – | |
| 29 Mar 2012 | 52-week high | +4.7% | +4.0% | +13.2% | +25.4% | never below | – | |
| 25 Oct 2011 | Above 200-day | +0.2% | +3.2% | +10.5% | +20.0% | −3.1% | – | |
| 5 Aug 2011 | Below 200-day | −2.3% | −0.8% | +3.9% | +18.5% | −6.3% | – | |
| 30 Mar 2011 | Above 200-day | +1.8% | +5.8% | −0.3% | +10.5% | −2.8% | – | |
| 8 Feb 2011 | Below 200-day | −0.7% | +3.2% | +3.7% | +10.7% | −2.9% | – | |
| 1 Feb 2011 | Down 10% | −3.7% | −2.1% | +6.7% | +7.2% | −7.1% | – | |
| 29 Sept 2009 | 52-week high | −0.2% | +14.6% | +24.0% | +43.9% | −2.6% | – | |
| 18 May 2009 | Above 200-day | +1.2% | +6.7% | +27.8% | +43.9% | −8.1% | – | |
| 6 Oct 2008 | Down 20% | −15.2% | −17.9% | −13.6% | +17.1% | −28.5% | – | |
| 16 Sept 2008 | Below 200-day | −16.4% | −24.3% | −29.7% | +7.2% | −35.8% | – | |
| 1 Jul 2008 | Down 10% | +2.3% | −7.6% | −24.4% | −11.6% | −37.5% | – | |
| 22 Apr 2008 | 52-week high | +0.5% | +1.0% | −22.9% | −24.5% | −38.2% | – | |
| 21 Feb 2008 | Above 200-day | +2.1% | +18.3% | +20.3% | −28.4% | −28.6% | – | |
| 22 Jan 2008 | Down 20% | +8.1% | +27.0% | +29.0% | −16.6% | −16.6% | – | |
| 21 Jan 2008 | Down 10% | +2.5% | +17.5% | +20.9% | −21.7% | −21.7% | – | |
| 21 Jan 2008 | Below 200-day | +2.5% | +17.5% | +20.9% | −21.7% | −21.7% | – | |
| 14 Nov 2007 | 52-week high | +5.2% | −9.5% | +11.5% | −22.0% | −26.1% | – | |
| 5 Sept 2007 | Above 200-day | +2.1% | +3.8% | +7.6% | +23.8% | −7.4% | – | |
| 23 Jul 2007 | Below 200-day | −7.9% | +1.6% | +0.2% | +21.1% | −8.9% | – | |
| 26 Apr 2007 | 52-week high | −0.9% | −6.7% | −3.4% | +13.5% | −14.6% | – | |
| 28 Feb 2007 | Below 200-day | +7.3% | +13.8% | +1.5% | +15.5% | −4.2% | – | |
| 3 Aug 2006 | Above 200-day | +12.4% | +12.9% | +18.8% | +13.1% | never below | – | |
| 6 Jun 2006 | Down 20% | −1.6% | +16.5% | +20.6% | +22.9% | −10.6% | – | |
| 6 Jun 2006 | Below 200-day | −1.6% | +16.5% | +20.6% | +22.9% | −10.6% | – | |
| 19 May 2006 | Down 10% | −11.4% | +0.8% | +11.1% | +13.8% | −18.6% | – | |
| 9 Jan 2006 | 52-week high | +12.0% | +22.3% | +1.1% | +22.7% | −9.8% | – | |
| 24 Oct 2005 | Below 200-day | +10.5% | +14.8% | +43.8% | +36.6% | −2.2% | – | |
| 20 Oct 2005 | Down 10% | +3.9% | +10.2% | +35.6% | +32.8% | −6.2% | – | |
| 12 Aug 2005 | 52-week high | +1.4% | −2.7% | +15.2% | +17.0% | −13.1% | – | |
| 24 May 2005 | Above 200-day | +6.4% | +17.8% | +13.9% | +35.6% | never below | back-calculated | |
| 7 Apr 2005 | Below 200-day | +0.7% | +14.4% | +24.3% | +54.4% | −3.9% | back-calculated | |
| 11 Jan 2005 | Down 10% | −0.6% | −6.2% | +9.7% | +17.4% | −9.2% | back-calculated | |
| 4 Oct 2004 | 52-week high | +0.9% | +14.1% | −2.4% | +20.0% | −7.0% | back-calculated | |
| 10 Sept 2004 | Above 200-day | +7.0% | +15.4% | +13.2% | +28.6% | never below | back-calculated | |
| 17 May 2004 | Below 200-day | +4.2% | +4.4% | +18.3% | +15.7% | −5.8% | back-calculated | |
| 1 Mar 2004 | Down 10% | −2.2% | +1.7% | −2.3% | +11.7% | −10.3% | back-calculated | |
| 6 Jun 2003 | 52-week high | +17.5% | +41.4% | +62.8% | +58.3% | never below | back-calculated | |
| 7 Apr 2003 | Above 200-day | −3.5% | +27.3% | +54.1% | +73.9% | −4.2% | back-calculated | |
| 10 Feb 2003 | Below 200-day | −3.4% | −2.6% | +31.3% | +74.1% | −5.5% | back-calculated | |
| 26 Dec 2002 | Above 200-day | +0.8% | −4.0% | +14.6% | +83.8% | −6.9% | back-calculated | |
| 7 Nov 2002 | Down 20% | +6.3% | +13.7% | +7.4% | +90.1% | never below | back-calculated | |
| 2 Sept 2002 | Above 200-day | −4.0% | −7.9% | −3.5% | +49.7% | −12.8% | back-calculated | |
| 26 Jul 2002 | Below 200-day | +0.7% | −9.4% | +2.5% | +29.0% | −11.1% | back-calculated | |
| 7 Jun 2002 | Below 200-day | +5.3% | +3.0% | −4.4% | +10.4% | −10.1% | back-calculated | |
| 23 May 2002 | Down 10% | +2.3% | −0.5% | −7.4% | −0.2% | −10.8% | back-calculated | |
| 14 Jan 2002 | 52-week high | −1.4% | +7.4% | +3.4% | +5.3% | −11.4% | back-calculated | |
| 6 Apr 2001 | Down 20% | +4.7% | +2.3% | +11.8% | +40.1% | −8.3% | back-calculated | |
| 12 Mar 2001 | Down 10% | −15.7% | −4.3% | +8.9% | +22.2% | −17.3% | back-calculated |
What the trend rules did here
₹1 lakh put into Pharma in January 2002 and held would be ₹30.7 lakh today after costs and tax. The better of the two simple rules, the 200-day average, would have left ₹14.0 lakh. Each rule holds Pharma while its signal is up and sits in a liquid fund otherwise, deciding at one day's close and trading at the next.
₹1 lakh from January 2002 to 20 Nov 2026, when all three rules had enough history. Costs: 0.10% of each trade and fund running costs. After tax: Indian capital-gains rules as they stood on each date, at the 30% slab, everything sold at the end. The ensemble trades a little every day, which no one would do in a taxable account, so it has no after-tax figure. The worst three years compare the rule's return a year with holding's over the same three years.
| Before tax | After tax | After tax, a year | Deepest fall | Worst three years against holding | When | More | |
|---|---|---|---|---|---|---|---|
| Buying and holding | ₹33.7 lakh | ₹30.7 lakh | 14.8% | −52%, Apr 2015 to Mar 2020 | – | – | |
| 10-month average | ₹16.1 lakh | ₹13.9 lakh | 11.2% | −32%, Apr 2006 to Jan 2008 | −22.0% points a year | Apr 2005 to May 2008 | |
| 200-day average | ₹18.5 lakh | ₹14.0 lakh | 11.2% | −33%, Apr 2015 to Mar 2020 | −16.0% points a year | Apr 2005 to May 2008 | |
| All 24 signals (the ensemble) | ₹15.4 lakh | not computed | – | −29%, Apr 2015 to Mar 2020 | −14.6% points a year | Apr 2005 to May 2008 |
Pharma: growth of 1 under each rule
Weekly, after costs, before tax. Log scale: equal slopes are equal returns.
How to read it. Buying and holding: 15.2% a year, worst fall -52%. The 10-month rule: 11.8%, worst fall -32%. The 200-day rule: 12.4%, worst fall -33%. Look first at the big falls, where the rule lines go flat, and then at the recoveries, where they lag.
Loading chart…
Each rule against buying and holding over the same dates, over the full history and, where it is three years or more, since NSE launched the index.
| Rule | Period | Rule, a year | Buy and hold | After tax, rule minus buy and hold | Rule's worst fall | Buy and hold's | Time invested | Switches a year |
|---|---|---|---|---|---|---|---|---|
| 10-month average | Full, from Jan 2002 | 11.8% | 15.2% | −3.6 pts | −32% | −52% | 70% | 1.0 |
| 200-day average | Full, from Jan 2002 | 12.4% | 15.2% | −3.6 pts | −33% | −52% | 69% | 3.5 |
| All 24 signals (the ensemble) | Full, from Jan 2002 | 11.6% | 15.2% | – | −29% | −52% | 59% | 5.1 |
| 10-month average | Since launch, Jul 2005 | 11.5% | 13.8% | −2.4 pts | −32% | −52% | 69% | 1.0 |
| 200-day average | Since launch, Jul 2005 | 11.6% | 13.8% | −2.5 pts | −33% | −52% | 68% | 3.4 |
| All 24 signals (the ensemble) | Since launch, Jul 2005 | 10.5% | 13.8% | – | −29% | −52% | 58% | 5.2 |
Not a test. These two rules were pre-registered on seven markets, and on those none beat buying and holding by more than luck would explain (the evidence). Run on all 127 investable markets here, the 10-month rule kept more after tax than buying and holding on 32 and the 200-day rule on 24; both had a shallower worst fall on nearly all of them. With this many markets, some would look good by chance, so one market's result says little about the next decade.
About this market
Nifty Pharma, in sectors. Source: NSE total-return index (NSE factsheet). History from Jan 2001. Its returns, calendar years, falls, valuation and holdings are on the index tab.
Back-calculated history. NSE launched this index in July 2005. Its history before that is a back-calculation: today's rules applied to the past. Rules chosen with that past in view tend to look better in it, so treat the pre-launch years, marked on each chart, with care.
Trend asks whether a market is rising; momentum asks whether it is rising faster than the others. Both look back from one month to a year: trend at six horizons (1, 2, 3, 6, 9 and 12 months), momentum at four (1, 3, 6 and 12). Every market is measured on its return above a liquid fund (the 91-day T-bill), so an index that only keeps pace with cash is not trending.
The trend score is the share of 24 signals that point up: four ways of asking whether a price is trending (above where it was, above its average, a short average above a long one, in the top half of its range), each at six horizons from one month to a year. 100 means all agree it is rising; 0 that all agree it is falling.
Uptrend and downtrend. Read once a week, a market enters an uptrend when its score reaches 70 (17 of 24 signals up) and stays in it until the score falls to 30 or below, when it enters a downtrend. "Uptrend since March 2026" means the score first reached 70 in March and has not fallen to 30 since. The gap between the two lines keeps a market from flipping every other week.
Describing is not forecasting. In my pre-registered tests no trend or momentum rule on indices beat buying and holding by more than luck would explain, and after tax every rule trailed on the large-cap indices. What the rules did reliably was cut the worst falls. What the tests found. Many indices are back-calculated by NSE before their launch; their pages say so and draw that history lighter.
The workings
The question
Data
Every chart has a table view, a CSV download and a link to its published JSON. Bundles are listed in data status.